CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Can-Fite BioPharma Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$1.89+0.13 (+7.39%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 26, 2026(first seen in filings) | 1-for-3000 reverse | Earlier per-share figures multiplied by 3000 |
| Jan 5, 2026 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Jan 9, 2023 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| May 10, 2019 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |